DNA compaction by mononuclear platinum cancer drug cisplatin and the trisplatinum anticancer agent BBR3464: Differences and similarities.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochimie

• Publication date

  2012-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biochi.2011.08.018PMID 21893159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fresh platinum complexes with promising antitumor activity.

  2010cited by this paper
• Compacting effect of BBR3464, a new-generation trisplatinum anticancer agent, on DNA.

  2010cited by this paper
• Status of non-classical mononuclear platinum anticancer drug development.

  2009cited by this paper
• Cisplatin induces loop structures and condensation of single DNA molecules

  2009influential reference
• Structural effects of nogalamycin, an antibiotic antitumour agent, on DNA.

  2008cited by this paper
• Atomic force microscopy as a multifunctional molecular toolbox in nanobiotechnology.

  2008cited by this paper
• Past, present and future of atomic force microscopy in life sciences and medicine

  2007cited by this paper
• The Discovery and Development of Cisplatin

  2006cited by this paper
• Multi-nuclear platinum drugs: a new paradigm in chemotherapy.

  2005influential reference
• Structural changes of DNA induced by mono- and binuclear cancer drugs.

  2005cited by this paper
• Imaging DNA molecules on mica surface by atomic force microscopy in air and in liquid

  2005cited by this paper
• Atomic force microscopy study of the structural effects induced by echinomycin binding to DNA.

  2005cited by this paper
• Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma.

  2004cited by this paper
• Polynuclear platinum drugs.

  2004cited by this paper
• Multi-nuclear platinum complexes as anti-cancer drugs

  2003cited by this paper
• Study of the modifications caused by cisplatin, transplatin, and Pd(II) and Pt(II) mepirizole derivatives on pBR322 DNA by atomic force microscopy.

  2002cited by this paper
• Platinum drugs in the treatment of non-small-cell lung cancer

  2002cited by this paper
• DNA bending and unwinding due to the major 1, 2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent

  2002cited by this paper
• Application of microencapsulation in textiles.

  2002cited by this paper
• DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464

  2002cited by this paper
• Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464).

  2002cited by this paper
• Computational consideration of cisplatin hydrolysis and acid dissociation in aqueous media: effect of total drug concentrations.

  2002cited by this paper
• Platinum-Based Drugs in Cancer Therapy

  2000cited by this paper
• BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

  2000cited by this paper
• Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

  1999cited by this paper
• Current status of platinum-based antitumor drugs.

  1999cited by this paper
• DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.

  1999influential reference
• Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy.

  1998cited by this paper
• Scanning Force Microscopy of Small Ligand-Nucleic Acid Complexes: Tris(o-phenanthroline)ruthenium(II) as a Test for a New Assay

  1997cited by this paper
• Scanning force microscopy of DNA deposited onto mica: equilibration versus kinetic trapping studied by statistical polymer chain analysis.

  1996cited by this paper
• Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA

  1996cited by this paper
• A novel assay for drug-DNA binding mode, affinity, and exclusion number: scanning force microscopy.

  1996cited by this paper
• The mechanism of action of antitumor platinum compounds.

  1979cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper

• What happened to BBR3464 and where to from here for multinuclear platinum-based anticancer drugs?

  2024cites this paper
• DNA Morphology: Global Alteration of DNA Topological States Induced by Chemotherapeutic Agents and Its Implication in Cancer

  2023cites this paper
• Impact of HMGB1 binding on the structural alterations of platinum drug-treated single dsDNA molecule.

  2023cites this paper
• Density-Functional Tight-Binding for Platinum Clusters and Bulk: Electronic vs Repulsive Parameters

  2019cites this paper
• The Role of an Alkyl–Phenyl Spacer on the Reactivity of Novel Platinum(II) Complexes with Thiourea Nucleophiles

  2017cites this paper
• Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.

  2015cites this paper
• DNA condensation induced by metal complexes

  2014cites this paper
• Metal-based Drugs

  2014cites this paper
• Organo-Metallic Compounds: Novel Molecules in Cancer Therapy

  2014cites this paper
• Transplatin enhances effect of cisplatin on both single DNA molecules and live tumor cells.

  2013cites this paper
• Platinum compounds: a hope for future cancer chemotherapy.

  2013cites this paper